CA
MDGL icon

Cliff Asness’s Madrigal Pharmaceuticals MDGL Stock Holding History

Cliff Asness’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Sell
15,827
-126
-0.8% -$64.5K ﹤0.01% 1673
2026
Q1 		$8.35M Buy
15,953
+5,947
+59% +$2.84M ﹤0.01% 1438
2025
Q4 		$5.83M Buy
10,006
+3,420
+52% +$1.75M ﹤0.01% 1486
2025
Q3 		$3.02M Buy
6,586
+3,419
+108% +$1.28M ﹤0.01% 1739
2025
Q2 		$958K Sell
3,167
-605
-16% -$180K ﹤0.01% 2230
2025
Q1 		$1.25M Sell
3,772
-1,710
-31% -$562K ﹤0.01% 1883
2024
Q4 		$1.69M Buy
5,482
+364
+7% +$102K ﹤0.01% 1622
2024
Q3 		$1.09M Buy
5,118
+508
+11% +$130K ﹤0.01% 1805
2024
Q2 		$1.29M Sell
4,610
-695
-13% -$165K ﹤0.01% 1641
2024
Q1 		$1.42M Sell
5,305
-808
-13% -$190K ﹤0.01% 1554
2023
Q4 		$1.41M Sell
6,113
-113
-2% -$19.8K ﹤0.01% 1479
2023
Q3 		$909K Sell
6,226
-301
-5% -$56.7K ﹤0.01% 1634
2023
Q2 		$1.51M Sell
6,527
-154
-2% -$41.7K ﹤0.01% 1390
2023
Q1 		$1.62M Buy
6,681
+4,796
+254% +$1.31M ﹤0.01% 1336
2022
Q4 		$547K Buy
+1,885
New +$184K ﹤0.01% 1783
2019
Q1 		– Sell
-4,955
Closed -$559K – 2197
2018
Q4 		$559K Sell
4,955
-2,086
-30% -$323K ﹤0.01% 1729
2018
Q3 		$1.51M Sell
7,041
-4,749
-40% -$1.19M ﹤0.01% 1520
2018
Q2 		$3.3M Buy
11,790
+6,052
+105% +$1.06M ﹤0.01% 1199
2018
Q1 		$670K Buy
+5,738
New +$708K ﹤0.01% 1820
2013
Q4 		– Sell
-774
Closed -$171K – 2587
2013
Q3 		$171K Sell
774
-1,660
-68% -$353K ﹤0.01% 2371
2013
Q2 		$425K Buy
+2,434
New +$635K ﹤0.01% 1961

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cliff Asness's MDGL Position: Q2 2026 in Review

Cliff Asness reduced its Madrigal Pharmaceuticals (MDGL) stake by 0.79% in Q2 2026, selling an estimated $64.5K and leaving 15,827 shares worth $8.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

Cliff Asness first reported a position in MDGL in Q2 2013 and has held it in 21 quarters since. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Cliff Asness held 15,827 shares of Madrigal Pharmaceuticals worth $8.5M as of Q2 2026.
  • Cliff Asness sold 126 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $64.5K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1673 holding.
  • Cliff Asness first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.